These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27593429)

  • 1. Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease - authors' reply.
    Zhulina Y; Cao Y; Amcoff K; Carlson M; Tysk C; Halfvarson J
    Aliment Pharmacol Ther; 2016 Oct; 44(7):770-1. PubMed ID: 27593429
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease.
    Yamamoto T; Shimoyama T; Kuriyama M
    Aliment Pharmacol Ther; 2016 Oct; 44(7):769-70. PubMed ID: 27593428
    [No Abstract]   [Full Text] [Related]  

  • 3. The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease.
    Zhulina Y; Cao Y; Amcoff K; Carlson M; Tysk C; Halfvarson J
    Aliment Pharmacol Ther; 2016 Sep; 44(5):495-504. PubMed ID: 27402063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
    Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Nielsen AM
    Ugeskr Laeger; 2014 Sep; 176(37):. PubMed ID: 25294035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Calprotectin as a Predictor of Relapse in Patients With Inflammatory Bowel Disease.
    Dai C; Jiang M; Sun MJ
    J Clin Gastroenterol; 2015 Sep; 49(8):715. PubMed ID: 25984977
    [No Abstract]   [Full Text] [Related]  

  • 7. Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.
    Burri E; Beglinger C
    Swiss Med Wkly; 2012; 142():w13557. PubMed ID: 22481443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic accuracy of faecal calprotectin in investigations for suspected inflammatory bowel disease in children.
    Auth MK
    Br J Gen Pract; 2015 Dec; 65(641):628-9. PubMed ID: 26622015
    [No Abstract]   [Full Text] [Related]  

  • 9. [Faecal calprotectin in inflammatory bowel disease].
    Sipponen T; Kolho KL
    Duodecim; 2011; 127(24):2631-7. PubMed ID: 22320105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: faecal calprotectin, clinical indices and the diagnosis of inflammatory bowel disease.
    Al Sulais E; AlAmeel T
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1166. PubMed ID: 30375681
    [No Abstract]   [Full Text] [Related]  

  • 11. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to: Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients.
    Ferreiro-Iglesias R; Barreiro-de Acosta M; Dominguez-Munoz JE
    J Clin Gastroenterol; 2019 Apr; 53(4):315-316. PubMed ID: 28520581
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease.
    Furnari M; Bodini G; Giannini EG; Savarino V
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1240-1. PubMed ID: 27137728
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.
    Srinivas NR
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1239-40. PubMed ID: 27137727
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors' reply.
    Ahmed I; Greenwood R; Costello B; Ratcliffe N; Probert C
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1241-2. PubMed ID: 27137729
    [No Abstract]   [Full Text] [Related]  

  • 16. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
    Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
    Sipponen T; Kolho KL
    Scand J Gastroenterol; 2010 Aug; 45(7-8):872-7. PubMed ID: 20377469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal calprotectin for the diagnosis of inflammatory bowel disease.
    Logan R
    BMJ; 2010 Jul; 341():c3636. PubMed ID: 20634348
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's disease-Authors' reply.
    Feathers A; Swaminath A; Ananthakrishnan AN; Falzon L; Li Ferry S
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1121. PubMed ID: 29105134
    [No Abstract]   [Full Text] [Related]  

  • 20. [Faecal calprotectin in inflammatory bowel diseases: review].
    Kallel L; Fekih M; Boubaker J; Filali A
    Tunis Med; 2011 May; 89(5):425-9. PubMed ID: 21557177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.